ABK Biomedical to build Missouri plant to produce Eye90 microsphere technology

URLhttps://www.bioprocessintl.com/deal-making/abk-bio
Sourcebioprocessintl.com
Date Published04/08/2026

Additional Reshoring Information:

Company/Division name ABK Biomedical
Parent companyABK Biomedical
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):15
Year reshoring announced:2026
Domestically, the work will be done:In-house
Country(ies) from which reshored:Canada
City reshored to:Ashland
State(s) reshored to:MO
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredimaging for radiotherapies
What domestic positive factors made reshoring more attractive?Proximity to customers/market, Skilled workforce availability/training, proximity to Univ of Missouri Research Reactor
Find Reshoring Articles